• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ev3

ev3

  1. Covidien's Wide-Moat Device Business Positioned Well for Long-Term Growth

    R&D investments and a narrowed focus have widened the firm's competitive advantages.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.